Kenneth S. Cragun
Equibles does not estimate personal net worth.
Get an email with a short summary when Alzamend Neuro, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALZN alertsAbout Kenneth S. Cragun
Earlier roles on record: Board Member at Algorhythm Holdings, Inc. (RIME) until September 5, 2024 and Board Member at TON Strategy Co (TONX) until August 7, 2025. TON Strategy Co reported in an 8-K filed August 8, 2025 that Kenneth S. Cragun resigned as Director, effective August 7, 2025. Algorhythm Holdings, Inc. reported in an 8-K filed September 10, 2024 that Kenneth S. Cragun resigned as Director, effective September 5, 2024. The proxy statement of Alzamend Neuro, Inc. reports total compensation of $100,000 for Kenneth S. Cragun in fiscal 2021, including a base salary of $100,000. Alzamend Neuro, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alzamend Neuro, Inc. includes Stephan S. Jackman (CEO), David J. Katzoff (CFO) and Milton C. Ault, III (Board Member).
“Effective as of August 7, 2025 (the "Effective Date"), Messrs. Kenneth S. Cragun, James P. Geiskopf, and Edmund C. Moy resigned from the Board and, to the extent applicable, all committees thereof (collectively, the "Resignations").”
“On September 5, 2024, Milton C. Ault, III, James M. Turner, and Kenneth S. Cragun, each notified the board of directors (the "Board") of Algorhythm Holdings, Inc. (the "Company") of his decision to resign from the Board, effective immediately.”
Affiliation history
-
Alzamend Neuro, Inc. (ALZN)
Proxy statement
CurrentStart not stated–present
Last confirmed March 31, 2023
-
2022-01-01–2024-09-05
-
2018-01-01–2025-08-07
Company network
Leadership on record at Alzamend Neuro, Inc.
- Stephan S. Jackman CEO
- David J. Katzoff CFO
- Milton C. Ault, III Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Alzamend Neuro, Inc. (ALZN) | Senior VP of Finance | $100,000 | $100,000 |